SCHEMBL3160237

SCHEMBL3160237

CCOC(=O)C(Cl)(Cl)C(=O)OCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
LMNA P02545 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ALOX15 P16050 1/20 0.43
MGAM O43451 1/20 0.43
GAA P10253 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
SOAT1 P35610 1/20 0.43
PKM P14618 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 1/20 0.43
CYP4F2 P78329 3/20 0.42
CYP4A11 Q02928 3/20 0.42
THRB P10828 1/20 0.42
TSHR P16473 2/20 0.41
ABCB11 O95342 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3314455 0.87 ALDH1A1 (0.46) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL8849154 0.87 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL9250185 0.87 CYP4F2 (0.39) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL28230745 0.87 ALDH1A1 (0.37) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL8585300 0.85 ALDH1A1 (0.40) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL7931648 0.84 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL56546 0.83
Boric Acid SCHEMBL28238397 0.83 PKM (0.38) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL28422245 0.82 ALDH1A1 (0.37) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL28502746 0.82 ALDH1A1 (0.37) ALDH1A1LMNAHSD17B10ALOX15MGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3377470-B1 PROCESS FOR THE SYNTHESIS OF INTERMEDIATES USEFUL FOR PREPARING 1,3,4-TRIAZINE DERIVATIVES FMC CORP (US) 2020-11-11 EP claimed
US-10294196-B2 Process for the synthesis of intermediates useful for preparing 1,3,4-triazine derivatives FMC CORP (US) 2019-05-21 US claimed
CN-109206548-A A kind of production technology of environment-friendly rubber 久裕电子科技(江苏)有限公司 2019-01-15 CN claimed
US-20180334427-A1 Process for the Synthesis of Intermediates Useful for Preparing 1,3,4-Triazine Derivatives FMC CORP (US) 2018-11-22 US claimed
EP-3377470-A1 PROCESS FOR THE SYNTHESIS OF INTERMEDIATES USEFUL FOR PREPARING 1,3,4-TRIAZINE DERIVATIVES FMC Corporation (US) 2018-09-26 EP claimed
CN-108349868-A Method for synthesizing the intermediate that can be used for preparing 1,3,4- triazines FMC有限公司 2018-07-31 CN claimed
CN-103374088-B A kind of ethylene-alpha-olefin copolymer and preparation method thereof SINOPEC CORP. (CN) 2015-09-16 CN claimed
CN-103374088-A Ethylene-alpha olefin copolymer and preparation method thereof CHINA PETROLEUM & CHEMICAL 2013-10-30 CN claimed
EP-1113028-B1 Process for production of olefin polymer with long chain branching BAYER AG (US) 2004-03-31 EP claimed
US-6384162-B1 COORDINATION CATALYST OF VANADIUM TRIS DIKETATE, HALOGENATED ORGANOALUMINUM, AND CHLORINATED ESTER ACTIVATOR; ETHYLENE PROPYLENE TETRAPOLYMERS WITH TWO DIOLEFIN MONOMERS SUCH AS 5-ETHYLIDENE-2-NORBORNENE AND 5-VINYLIDINE-2-NORBORNENE BAYER AKTIENGESELLSCHAFT (DE) 2002-05-07 US claimed
EP-1113028-A1 Process for production of olefin polymer with long chain branching Bayer Inc. (CA) 2001-07-04 EP claimed
US-5919877-A POLYMERIZATION CATALYST CONSISTING OF VANADIUM(III) ACETYLACETONATE AND A HYDROCARBON SOLUTION OF AN ALKYLALUMINUM HALIDE ENICHEM ELASTOMERI S.R L. (IT) 1999-07-06 US claimed
EP-0546629-B1 Process for preparing elastomeric copolymers of ethylene with a high tensile strength of the crude product ENICHEM ELASTOMERS (IT) 1997-02-26 EP claimed
JP-9124735-A None JP disclosed
JP-5262826-A None JP disclosed
US-12559483-B2 Process for the preparation of fluoxastrobin and intermediates thereof UPL LTD (IN) 2026-02-24 US disclosed
CN-1133301-A Load type catalyst system for producing ethylene/propene copolymer ENICHEM ELASTOMERS (IT) 1996-10-16 CN disclosed
EP-0717050-A1 Supported catalytic system for the production of ethylene propylene copolymers ENICHEM ELASTOMERI S.r.l. (IT) 1996-06-19 EP disclosed
EP-0687665-A1 Process for preparing 2,2-dichloro-malonic acid esters HÜLS AKTIENGESELLSCHAFT (DE) 1995-12-20 EP disclosed
JP-H05262826-A PRODUCTION OF ELASTOMERIC OLEFIN COPOLYMER UBE IND LTD 1993-10-12 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10294196-B2 Process for the synthesis of intermediates useful for preparing 1,3,4-triazine derivatives DAZAP1, TALDO1, GMDS ALDH1A1 395/4885LMNA 3909/4885HSD17B10 1637/4885
US-20180334427-A1 Process for the Synthesis of Intermediates Useful for Preparing 1,3,4-Triazine Derivatives DHPS, CYP4Z1, NISCH ALDH1A1 800/4885LMNA 2871/4885HSD17B10 1396/4885
US-12559483-B2 Process for the preparation of fluoxastrobin and intermediates thereof P2RX7, P2RX6, CTRB1 ALDH1A1 920/4885LMNA 1078/4885HSD17B10 3567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.